Targeting evolution to inhibit antibiotic resistance-Reference-Cited by-同舟云学术

Targeting evolution to inhibit antibiotic resistance

Published:2020-06-08 Issue:20 Volume:287 Page:4341-4353
ISSN:1742-464X
Container-title:The FEBS Journal
language:en
Short-container-title:FEBS J.

Author:

Merrikh Houra¹²^ORCID,Kohli Rahul M.³⁴^ORCID

Affiliation:

1. Department of Biochemistry Vanderbilt University Nashville TN USA

2. Department of Pathology, Microbiology, and Immunology Vanderbilt University Medical Center Nashville TN USA

3. Department of Medicine Perelman School of Medicine University of Pennsylvania Philadelphia PA USA

4. Department of Biochemistry and Biophysics Perelman School of Medicine University of Pennsylvania Philadelphia PA USA

Funder

Bill and Melinda Gates Foundation

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/febs.15370

Reference95 articles.

1. The antibiotic resistance crisis: part 1: causes and threats;Ventola CL;P T,2015

2. Review on Antimicrobial Resistance(2016)Tackling drug‐resistant infections globally: final report and recommendations. The Review on Antimicrobial Resistance.

3. Targets for Combating the Evolution of Acquired Antibiotic Resistance

4. Molecular mechanisms that confer antibacterial drug resistance

5. Resistance to rifampicin: a review

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-mutagenic agent targeting LexA to combat antimicrobial resistance in mycobacteria;Journal of Biological Chemistry;2024-09

2. Bioenergetic stress potentiates antimicrobial resistance and persistence;2024-07-13

3. Integrative genomics would strengthen AMR understanding through ONE health approach;Heliyon;2024-07

4. The LexA–RecA* structure reveals a cryptic lock-and-key mechanism for SOS activation;Nature Structural & Molecular Biology;2024-05-16

5. A Study of the Synergistic Effects of Essential Oils from Origanum compactum and Origanum elongatum with Commercial Antibiotics against Highly Prioritized Multidrug-Resistant Bacteria for the World Health Organization;Metabolites;2024-04-07